We developed a multiplex immunoassay magneto-nanosensor chip to investigate the capacity of a panel of four CaP-related autoantibodies, and PSA and free/total PSA ratio to differentiate CaP from non-cancer cases. The gene discussed is KLK3; the disease is cancer.